BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1799284)

  • 1. Intraperitoneal injections of nanogram CCK-8 doses inhibit feeding in rats.
    Canova A; Geary N
    Appetite; 1991 Dec; 17(3):221-7. PubMed ID: 1799284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic-portal infusion reduces the satiating potency of CCK-8.
    Greenberg D; Smith GP
    Physiol Behav; 1988; 44(4-5):535-8. PubMed ID: 3237843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MK-329 blocks the inhibition of alcohol intake by CCK-8.
    Carr BA; Ballou JD; Snell JC; Kulkosky PJ
    Peptides; 1993; 14(6):1193-7. PubMed ID: 8134301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholecystokinin interacts with prefeeding to impair runway performance.
    Cox JE
    Behav Brain Res; 1986 Jul; 21(1):29-36. PubMed ID: 3741594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specificity of cholecystokinin satiety effect: reduction of food but not water intake.
    Mueller K; Hsiao S
    Pharmacol Biochem Behav; 1977 Jun; 6(6):643-6. PubMed ID: 263547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined injection potentiates the satiety effects of pancreatic glucagon, cholecystokinin, and bombesin.
    Hinton V; Rosofsky M; Granger J; Geary N
    Brain Res Bull; 1986 Nov; 17(5):615-9. PubMed ID: 3801925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracerebroventricular injections of cholecystokinin octapeptide suppress feeding in rats--pharmacological characterization of this action.
    Schick RR; Yaksh TL; Go VL
    Regul Pept; 1986 Jul; 14(4):277-91. PubMed ID: 3749526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infusion of CCK-8 into hepatic-portal vein fails to reduce food intake in rats.
    Greenberg D; Smith GP; Gibbs J
    Am J Physiol; 1987 May; 252(5 Pt 2):R1015-8. PubMed ID: 3578549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic administration of cholecystokinin (CCK) inhibits operant water intake in rats: implications for the CCK-satiety hypothesis.
    Ebenezer IS
    Proc Biol Sci; 1996 Apr; 263(1369):491-6. PubMed ID: 8637930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut vagal afferents are necessary for the eating-suppressive effect of intraperitoneally administered ginsenoside Rb1 in rats.
    Shen L; Wang DQ; Lo CC; Arnold M; Tso P; Woods SC; Liu M
    Physiol Behav; 2015 Dec; 152(Pt A):62-7. PubMed ID: 26384952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proglumide fails to increase food intake after an ingested preload.
    Schneider LH; Gibbs J; Smith GP
    Peptides; 1986; 7(1):135-40. PubMed ID: 3714531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diminished satiation in rats exposed to elevated levels of endogenous or exogenous cholecystokinin.
    Covasa M; Marcuson JK; Ritter RC
    Am J Physiol Regul Integr Comp Physiol; 2001 Feb; 280(2):R331-7. PubMed ID: 11208559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholecystokinin and bombesin act independently to decrease food intake in the rat.
    Stein LJ; Woods SC
    Peptides; 1981; 2(4):431-6. PubMed ID: 6276871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cholecystokinin octapeptide (CCK-8) on food intake in adult and aged rats under different feeding conditions.
    Voigt JP; Huston JP; Voits M; Fink H
    Peptides; 1996; 17(8):1313-5. PubMed ID: 8971925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ineffectiveness of cholecystokinin in impairing runway performance.
    Cox JE; Brown PT; Toney RJ; Wiebe DJ
    Behav Brain Res; 1984 Oct; 14(1):41-50. PubMed ID: 6097286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic estradiol replacement increases the satiety effect of CCK-8 in ovariectomized rats.
    Geary N; Trace D; McEwen B; Smith GP
    Physiol Behav; 1994 Aug; 56(2):281-9. PubMed ID: 7938239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of cholecystokinin-octapeptide on food intake and consummatory behavior in lactating rats.
    Wager-Srdar SA; Levine AS
    Physiol Behav; 1991 Aug; 50(2):331-6. PubMed ID: 1745677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma concentrations of cholecystokinin octapeptide and food intake in male rats treated with cholecystokinin octapeptide.
    Lindén A; Uvnäs-Moberg K; Forsberg G; Bednar I; Södersten P
    J Endocrinol; 1989 Apr; 121(1):59-65. PubMed ID: 2565947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCK-8 and CCK-58 differ in their effects on nocturnal solid meal pattern in undisturbed rats.
    Goebel-Stengel M; Stengel A; Wang L; Ohning G; Taché Y; Reeve JR
    Am J Physiol Regul Integr Comp Physiol; 2012 Oct; 303(8):R850-60. PubMed ID: 22874423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraperitoneal, but not subcutaneous, administration of the sulphated cholecystokinin octapeptide (CCK-8S) inhibits operant and nonoperant food intake in rats: implications for the CCK-satiety hypothesis.
    Ebenezer IS
    Methods Find Exp Clin Pharmacol; 1999 Apr; 21(3):167-71. PubMed ID: 10389118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.